Your browser doesn't support javascript.
loading
Emicizumab initiation and bleeding outcomes in people with hemophilia A with and without inhibitors: A single-center report.
Warren, Beth Boulden; Chan, Adrian; Manco-Johnson, Marilyn; Branchford, Brian R; Buckner, Tyler W; Moyer, Genevieve; Gibson, Elizabeth; Thornhill, Dianne; Wang, Michael; Ng, Christopher J.
Afiliação
  • Warren BB; Hemophilia and Thrombosis Center University of Colorado Anschutz Medical Campus Aurora CO USA.
  • Chan A; Hemophilia and Thrombosis Center University of Colorado Anschutz Medical Campus Aurora CO USA.
  • Manco-Johnson M; Hemophilia and Thrombosis Center University of Colorado Anschutz Medical Campus Aurora CO USA.
  • Branchford BR; Hemophilia and Thrombosis Center University of Colorado Anschutz Medical Campus Aurora CO USA.
  • Buckner TW; Versiti Medical Sciences Institute Milwaukee WI USA.
  • Moyer G; Hemophilia and Thrombosis Center University of Colorado Anschutz Medical Campus Aurora CO USA.
  • Gibson E; Hemophilia and Thrombosis Center University of Colorado Anschutz Medical Campus Aurora CO USA.
  • Thornhill D; Hemophilia and Thrombosis Center University of Colorado Anschutz Medical Campus Aurora CO USA.
  • Wang M; Hemophilia and Thrombosis Center University of Colorado Anschutz Medical Campus Aurora CO USA.
  • Ng CJ; Hemophilia and Thrombosis Center University of Colorado Anschutz Medical Campus Aurora CO USA.
Res Pract Thromb Haemost ; 5(5): e12571, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34377887

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Qualitative_research Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Qualitative_research Idioma: En Ano de publicação: 2021 Tipo de documento: Article